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Abstract
Methods that infer causal dependence from observational data
are central to many areas of science, including medicine, eco-
nomics, and the social sciences. A variety of theoretical prop-
erties of these methods have been proven, but empirical eval-
uation remains a challenge, largely due to the lack of obser-
vational data sets for which treatment effect is known. We
propose and analyze observational sampling from randomized
controlled trials (OSRCT), a method for evaluating causal
inference methods using data from randomized controlled tri-
als (RCTs). This method can be used to create constructed
observational data sets with corresponding unbiased estimates
of treatment effect, substantially increasing the number of
data sets available for evaluating causal inference methods.
We show that, in expectation, OSRCT creates data sets that
are equivalent to those produced by randomly sampling from
empirical data sets in which all potential outcomes are avail-
able. We analyze several properties of OSRCT theoretically
and empirically, and we demonstrate its use by comparing the
performance of four causal inference methods using data from
eleven RCTs.
Introduction
Researchers in machine learning and statistics have become
increasingly interested in methods that can estimate causal
effects from observational data. Such interest is understand-
able, given the centrality of causal questions in fields such as
medicine, economics, sociology, and political science (Mor-
gan and Winship 2015). Causal inference has also emerged
as an important class of methods for improving the explain-
ability and fairness of machine learning systems, since causal
models explicitly represent the underlying mechanisms of
systems and their likely behavior under counterfactual condi-
tions (Kusner et al. 2017; Pearl 2019).
However, evaluating causal inference methods is typi-
cally far more challenging than evaluating methods that con-
struct purely associational models. Both types of methods
can be analyzed theoretically. However, empirical analysis—
long a driver of research progress in machine learning and
statistics—has been increasingly recognized as vital for re-
search progress in causal inference (e.g., Dorie et al. 2019;
Gentzel, Garant, and Jensen 2019), and empirical evaluation
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is substantially more challenging to perform in the case of
causal inference. Many associational models (e.g., classifiers
and conditional probability estimators) can be evaluated us-
ing cross-validation or held-out test sets. However, causal
inference aims to estimate the value or distribution of an
outcome variable under intervention, and evaluating such es-
timates requires an alternative route to estimating the effects
of such intervention.
Most easily available data sets are either experimental
(which can yield unbiased estimates of treatment effect) or
observational (for which treatment effect is unknown). Since
most causal inference methods are designed to infer causal
dependence from observational data, accurate evaluation re-
quires both observational data and corresponding unbiased
estimates of treatment effect. Several recent efforts have at-
tempted to address this problem (e.g., Dorie et al. 2019;
Gentzel, Garant, and Jensen 2019; Tu et al. 2019; Shimoni
et al. 2018), most of which collect or modify data specifically
for the purpose of evaluation. Some approaches induce depen-
dence between variables in specially constructed or selected
data, while others repurpose a simulator to produce data for
evaluation. These approaches are promising and beneficial to
the community, but creating individual, specialized new data
sets is difficult and time-consuming, limiting the number of
data sets available and thus limiting research progress.
We propose to exploit an additional source of data for
evaluating causal inference methods: randomized controlled
trials. Randomized controlled trials (RCTs) are designed and
conducted for the express purpose of providing unbiased esti-
mates of treatment effect. Many RCT data sets are publicly
available, and more become available every day. Previous
work has described how to sub-sample a specialized type
of experimental data (one in which all potential outcomes
are observed) to create constructed observational data sets.1
Surprisingly, this basic approach can be modified to produce
constructed observational data from RCTs as well. Specifi-
cally, we: (1) Describe an algorithm to induce confounding
bias in RCT data by sub-sampling, and prove that this ap-
1The term ”constructed observational data” denotes empirical
data to which additional properties common in observational data
(e.g., confounding) have been synthetically introduced. This term is
distinct from constructed observational studies, which are studies
that collect and compare both experimental and observational data
from the same domain (see “Related Work”).
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proach is equivalent, in expectation, to the data generating
process assumed by the potential-outcomes framework, a
longstanding theoretical framework for causal inference; (2)
Demonstrate the feasibility of this approach by applying
multiple causal inference methods to observational data con-
structed from RCTs2; and (3) Present a method for using the
data rejected by the sub-sampling for evaluation, and show
that it is equivalent to a held-out test set.
Creating Observational Data from
Randomized Controlled Trials
Consider a data generating process that produces a binary
treatment T ∈ {0, 1}, outcome Y , and multiple covariates
C = {C1, C2, ...Ck}, each of which may be causal for out-
come.3 We define Yi(t) to be the outcome for unit i under
treatment t, referred to as a potential outcome. For each unit
i, both treatment values Ti = 0 and Ti = 1 are set by in-
tervention and both potential outcomes Yi(1) and Yi(0) are
measured. We refer to this type of data, where all potential
outcomes are observed, as all potential outcomes (APO) data,
denoted DAPO. Note that, due to the use of explicit interven-
tions, such a data generating process produces experimental,
rather than observational, data.
Recently, some researchers (Louizos et al. 2017; Gentzel,
Garant, and Jensen 2019) have proposed sampling from APO
data to produce constructed observational data. Such data sets
are produced by probabilistically sampling a treatment value
(and its corresponding outcome value) for every unit based on
the values of one or more covariates (P (T |C) := f(C)). We
refer to C as the biasing covariates. This procedure, shown
in Algorithm 1, induces causal dependence between C and
T , creating a confounder when C also causes Y . We refer
to such a data generating process as observational sampling
from all potential outcomes (OSAPO) and denote a given data
set generated in this way as DOSAPO. OSAPO is the data
generating process assumed under the potential outcomes
framework (Rubin 2005).
Data sets produced by OSAPO are extremely useful for
evaluating causal inference methods. Causal inference meth-
ods can estimate treatment effect in DOSAPO, and these es-
timates can be compared to estimates derived from DAPO.
Furthermore, the process of inducing bias by sub-sampling
allows for a degree of control that can be exploited to evalu-
ate a method’s resilience to confounding, by systematically
varying the strength and form of dependence and whether
variables in C are observed. However, very few experimental
data sets exist that record all potential outcomes for every
unit, severely limiting the applicability of this approach.
Observational Sampling of RCTs
Now consider a slightly different data generating process, in
which treatment is randomly assigned and only one potential
outcome is measured for each unit i, producing either Yi(1)
or Yi(0), but not both. This is the data generating process
2Pointers to the data sets used in this paper, and R code to
perform observational sampling, will be released upon publication.
3For ease of exposition, we describe the approach using binary
treatment, but the approach is more general.
implemented by RCTs, in which every unit is randomly as-
signed a treatment value, and the outcome for that treatment
is measured. Vast numbers of RCTs are conducted each year,
and data sets from many of them are available publicly. In
addition, growing efforts toward open science are continually
increasing the number of publicly available RCT data sets.
This raises an intriguing research question: Can RCTs
be sub-sampled to produce constructed observational data
sets with the same properties as those produced by APO
sampling?
We describe one such sampling procedure in Algorithm 2
— observational sampling from randomized controlled trials
(OSRCT)—which produces a data sample denoted DOSRCT .
As in APO sampling, covariates C bias the selection of a sin-
gle treatment value for every unit i. If unit i actually received
the selected treatment ts, we add i to DOSRCT . Otherwise,
that unit is ignored. As we show below, when treatment is
binary and treatment and control groups are equal in size, the
resulting constructed observational data set is, in expectation,
half the size of the original, regardless of the form of the
biasing. As discussed in “What Can OSRCT Evaluate?”, a
causal inference method can then be applied to this data, and
the results can be compared to the unbiased effect estimate
from the original RCT data. This basic approach is shown in
Figure 2.
An RCT can be thought of as a data set where one po-
tential outcome for every unit is missing at random. Since
OSRCT uses the biasing covariates to select treatment, and
treatment was assigned randomly, the sub-sampling process
only changes the dependence between the biasing covariates
and treatment. This is the same as in APO sample. The prob-
ability of a given unit-treatment pair being included in the
sub-sample is proportional in APO and RCT sampling. That
is, DOSRCT is equivalent to a random sample of DOSAPO.
Theorem 1. For RCT data set DRCT , APO data set DAPO,
and binary treatment T ∈ {0, 1} with P (T = 1) = P (T =
0) = 0.5 in DRCT , and units i, PDOSRCT (Ti = t) = 0.5 ∗
PDOSAPO (Ti = t), for all units i.
Proof. For every unit i and any treatment t′, the biasing
covariates Ci are used to probabilistically select a treatment,
which we denote Tsi, with probability P (Tsi = t′|Ci).
PDOSAPO (Ti = t
′) = P (Tsi = t′|Ci) (1)
PDOSRCT (Ti = t
′) = P (Ti = t′)P (Tsi = t′|Ci) (2)
= 0.5P (Tsi = t
′|Ci) (3)
Sub-sampling DOSAPO uniformly at random is equivalent to
multiplying PDOSAPO (Ti = t
′) by a scaling factor, s. When
s = 0.5, PDOSRCT (Ti = t
′) = PDOSAPO (Ti = t
′).
Intuitively, the procedure outlined in Algorithm 1 works
because treatment is randomly assigned in RCTs. The data
is sub-sampled based solely on the value of a probabilistic
function of the biasing covariates, which selects a value of
treatment for every unit i. Since the observed treatment is
randomly assigned, it contains no information about any of
i’s covariates. The only bias introduced by this sub-sampling
procedure is the intended bias: a particular form of causal
dependence from C to T .
Figure 1: Two procedures for sampling constructed observational data sets from experimental data. Left: From all potential
outcomes (APO) data. Right: From randomized controlled trial (RCT) data. For some function f : D(C)→ {p ∈ R : 0 < p < 1}
Note that while Theorem 1 assumes equal probability of
treatment and control, the approach generally applies even
when P (T = 1) 6= 0.5. In this case, instead of sub-sampling
DOSAPO by a factor of 0.5, the scaling factor is selected based
on the treatment value. Since treatment is based solely on the
value of the biasing covariates, this is equivalent to modifying
the form of the biasing function.
One potential disadvantage of this approach is that sub-
sampling to induce bias necessarily reduces the size of the
resulting sample. Somewhat surprisingly, however, the degree
of this reduction does not depend on the intensity of the
biasing.
Theorem 2. For binary treatment T ∈ {0, 1} and RCT data
set DRCT , if either P (T = 1) = P (T = 0) = 0.5, or
E[P (Ts = 1|C)] = 0.5, then E[|DOSRCT |] = 0.5|DRCT |.
A proof is provided in the Supplementary Material.
What Can OSRCT Evaluate?
The constructed observational data created by OSRCT has a
substantial benefit over purely observational data: Unbiased
estimates of causal effect can be obtained from the original
RCT data, which can be compared to effect estimates from
causal inference methods. In a well-designed RCT, treatment
assignment is randomized such that, in expectation, the treat-
ment and control groups are equivalent. This enables the
unbiased estimation of the sample average treatment effect
(ATE) asE[yi(1)|ti = 1]−E[yi(0)|ti = 0], where ti denotes
the actual treatment received by unit i. This estimate can be
compared to estimates made by causal inference methods
applied to the constructed observational data.
However, unlike APO data, RCT data only contains one
treatment-outcome pair for every unit, limiting both the avail-
able effect estimates and how these data sets can be used.
RCTs measure the effect of a single randomized intervention
do(Ti = ti) for every unit in the data set. Thus, we cannot
estimate individual treatment effect (ITE) from RCT data,
a measurement which is available when using APO data.
However, OSRCT data can be used to evaluate a method’s
ability to estimate the unit-level effects of interventions. Any
causal inference method that can estimate E[Y |do(T = t)]
can be evaluated by comparing those estimates against mea-
surements in the RCT data.
Using the Complementary Sample for Evaluation
One challenge when evaluating causal inference methods on
their ability to estimate unit-level effects of interventions is
the need for a held-out test set. The constructed observational
data is constructed by sub-sampling the original RCT data.
This means that evaluating on all of the RCT data may pro-
duce a biased result by testing on a superset of the training
data. One potential solution is to divide the RCT data into
separate training and test sets. However, since OSRCT neces-
sarily reduces the size of the training data by sub-sampling,
the extra requirement of holding out a test set limits the
number of RCTs that can be used, since not all randomized
experiments will have enough data to learn effective models
after two rounds of sub-sampling.
A more data-efficient approach is to use the data rejected
by the biased sub-sampling. OSRCT sub-samples RCT data
to create a probabilistic dependence between the biasing co-
variates and treatment. Based on the values of the biasing
covariates, a treatment is selected for every unit. If that treat-
ment is present in the data, the unit is included in the sample;
otherwise the unit is rejected. This rejected sample (which we
call the complementary sample) also has a causal dependence
from the biasing covariates to treatment. The only difference
is that the form of that dependence is the complement of that
for the accepted sample, such that covariate values that lead to
a high probability of treatment in the accepted sample would
lead to a low probability of treatment in the complementary
sample. Because we know the functional form of this induced
bias, we can weight the data points in the complementary
sample according to their probability of being included in the
accepted sample. In aggregate, this type of weighting allows
the complementary sample to approximate the distribution of
the training data, and thus be used for testing. This is equiva-
lent to inverse propensity score weighting (Rosenbaum and
Rubin 1983).
Theorem 3. For binary treatment T ∈ {0, 1}, biasing
covariates C, outcome Y , estimated outcome Yˆ , biased
Figure 2: The process of creating observational-style data from a randomized controlled trial.
sample DOSRCT and complementary sample D¯OSRCT , let
ps = P (Tsi = ti|Ci). Then, E[Yˆ − Y ] for DOSRCT =
E[(Yˆ − Y ) ps1−ps ] for D¯OSRCT .
A proof is provided in the Supplementary Material.
Assumptions, Limitations, and Opportunities
The validity of evaluation with OSRCT depends on several
standard assumptions about the validity of the original RCT.
Specifically, it assumes that treatment assignment is random-
ized and that all sampled units complete the study (no “drop-
out”). Intriguingly, one standard assumption—that intent to
treat does not differ from actual treatment—is not necessary.
Even if this assumption is violated, the estimated treatment
effect will correspond to the effect of intending to treat, and
this estimand can still be used to evaluate the effectiveness
of methods for observational causal inference.
Evaluation with OSRCT has some limitations. OSRCT
can induce dependence between any covariate and treatment,
but it cannot induce dependence between any covariate and
outcome. In addition, while the original RCT data can yield
an unbiased estimate of the effect of treatment on outcome, it
cannot produce such estimates for any other pair of variables.
Constructing observational data also provides some unique
opportunities. OSRCT produces data with non-random treat-
ment assignment, and allows for variation in the level and
form of that non-randomness. Additional factors of observa-
tional studies can also be simulated, such as measurement
error, selection bias, and lack of positivity. While some of
these may reduce the sample size of the constructed observa-
tional data due to additional sub-sampling, this can allow for
the evaluation of a causal inference method’s robustness to
many features of real-world data.
Related Work
The closest prior work (Li et al. 2011) uses an identical idea
for a subtly different task: estimating the reward of a con-
textual bandit policy without having to actually execute that
policy. Specifically, they propose to evaluate a (non-random)
contextual policy by sampling from the data produced by
a randomized policy. They show that the resulting estimate
is unbiased, despite its use of only a subsample of the data
originally produced by the randomized policy. This method
is widely employed to evaluate methods in fields such as
computational advertising and recommender systems, and
it has been extended with approaches such as bootstrapping
(Mary, Preux, and Nicol 2014).
OSRCT exploits the same idea but in a different setting. In
our setting, we have no interest in estimating the effect of a
contextual policy that is known to the agent (which is some-
what analogous to what, in observational causal inference, is
referred to as the ”average treatment effect on the treated”).
Instead, our goal is to determine how well a given method
estimates the average treatment effect (which, in contextual
bandits, would be formulated as the reward difference be-
tween two specific policies), even though the algorithm only
has access to the actions and outcomes of a single unknown
and non-randomized policy.
Despite the similarity of tasks, this approach—
observational sampling from RCTs—is almost entirely
unknown within the causal inference community. For
example, two recent papers that contain reviews of existing
evaluation methods for causal inference methods—Dorie et
al. (2019) and Gentzel et al. (2019)—do not even mention
this approach, despite the fact that it overcomes many of the
most serious threats to validity for evaluation studies (e.g.,
reproducibility, realistic data distributions and complexity of
treatment effects, multiple possible levels of confounding).
A handful of papers have applied it in a one-off manner to
evaluate causal inference methods (e.g., Kallus, Puli, and
Shalit 2018; Kallus and Zhou 2018), but it has not been
explicitly formalized or its advantages clearly described. As
a result, it is almost never used.
In addition to this prior work on sampling for evaluating
contextual bandit policies, other prior work has explicitly fo-
cused on evaluation methods in causal inference. This work
has applied a variety of approaches to creating observational
data sets such that a derived estimated treatment effect can
be compared to some objective standard. The ideal approach
would score highly on at least three characteristics: data avail-
ability (many data sets with the required characteristics can
be easily obtained); internal validity (differences between
estimated treatment effect and the standard can only be at-
tributed to bias in the estimator); and external validity (the
performance of the estimator will generalize well to other
settings). Of three broad classes of prior work, each suffers
from some deficiencies and none clearly dominate the others.
The first class of prior work uses observational data sets
with known treatment effect. One approach gathers obser-
vational data about phenomena that are so well-understood
that the causal effect is obvious (e.g., Mooij et al. 2016). Un-
fortunately, such situations are relatively rare, limiting data
availability. Another approach is to use data from matched
pairs of observational and experimental studies (e.g., Dixit
et al. 2016; Sachs et al. 2005). In many ways, such data
sets appear to represent a nearly ideal scenario for evaluat-
ing methods for inferring causal effect from observational
data. However, pairs of directly comparable observational
and experimental studies have low data availability, and using
paired studies with different settings or variable definitions
can greatly reduce internal validity. Some “constructed ob-
servational studies” intentionally create matched pairs of ex-
perimental and observational data sets (e.g., LaLonde 1986;
Hill, Reiter, and Zanutoo 2004; Shadish, Clark, and Steiner
2008), but these studies also have low data availability.
Another class of prior work generates observational data
from synthetic or highly controlled causal systems (e.g., Tu
et al. 2019; Gentzel, Garant, and Jensen 2019; Louizos et al.
2017; Kallus, Mao, and Udell 2018). In this way, the treat-
ment effect is either directly known or can be easily derived
from experimentation. Observational data is typically ob-
tained via some biased sampling of the experimental data,
often a variety of APO sampling. In the case of entirely syn-
thetic data, data availability and internal validity are both
high, but external validity is low, and such studies are often
criticized as little more than demonstrations. External valid-
ity typically increases somewhat for highly controlled causal
systems, but data availability drops significantly.
The final and newest class of existing work augments an
existing observational study with a synthetic outcome, re-
placing the original outcome measurement (e.g., Dorie et al.
2019; Shimoni et al. 2018). Given the synthetic nature of the
outcome, the causal effect is known. This class of approach
has relatively high data availability, and it trades some loss of
external validity (because real outcome measurements are re-
placed with synthetic ones) to gain internal validity (because
the true treatment effect is known). Note particularly that
both the treatment effect and the confounding are synthetic,
because the function that determines the synthetic outcome
determines how both the treatment and potential confounders
affect the value of outcome.
The approach proposed here—OSRCT—augments, rather
than replaces, these existing approaches. It occupies a unique
position because it simultaneously has fairly high data avail-
ability, internal validity, and external validity. OSRCT’s data
availability is relatively high because it can be applied to data
from any moderately large RCT. Only synthetic data gener-
ators and approaches that augment observational data with
synthetic outcomes probably have higher data availability,
but both suffer in terms of external validity. OSRCT’s inter-
nal validity is relatively high because there exist many well-
designed RCTs. Using synthetic data generators or highly
controlled causal systems will typically produce somewhat
higher internal validity, as will observational data with syn-
thetic outcomes, but this is done at the cost of external validity
or data availability. Finally, OSRCT’s external validity is rel-
atively high because the distributions of all variables and
the outcome function occur naturally, while only the con-
founding is synthetic. Only observational studies with known
treatment effect have higher external validity, and these suffer
from severe limitations on data availability.
Are RCT Data Sets Available?
OSRCT has the benefit of leveraging existing empirical data
rather than requiring the creation of new data sets specifically
for evaluating causal inference methods, but it does require
that data from RCTs be available and generally accessible
to causality researchers. Fortunately, this is increasingly the
case. While many repositories that host RCTs are restricted
for reasons of privacy and security, many other repositories
allow access with only minimal restrictions. In some cases,
access requires only registering with the repository and agree-
ing not to re-distribute the data or attempt to de-anonymize it.
As long as these data sharing agreements are adhered to, such
data can be easily acquired by causality researchers. This
includes repositories such as Dryad, the Yale Institution for
Social and Policy Studies Repository, the NIH National In-
stitute on Drug Abuse Data Share Website, the University of
Michigan’s ICPSR repository, the UK Data Service, and the
Knowledge Network for Biocomplexity. An even larger set
of repositories restricts access but will make data available
upon reasonable request. Additional information about these
repositories can be found in the Supplementary Material.
In addition, funding agencies and journals are increasingly
requiring that researchers make anonymized individual pa-
tient data available upon reasonable request (Godlee and
Groves 2012; Ohmann et al. 2017). For example, the United
States’ National Institutes of Health (NIH) recently requested
public feedback on a proposed data sharing policy with the
aim of improving data management and the sharing of data
created by NIH-funded projects (NIH 2019). There is also in-
creasing awareness and discussion in the medical community
about the importance of sharing individual patient data, to
allow for greater transparency and re-analysis (Drazen 2015;
Kuntz et al. 2019; Banzi et al. 2019; Suvarna 2015). All of
this suggests increasing availability of individual patient data
from randomized controlled trials.
Demonstration
To demonstrate the feasibility of OSRCT, we examine the
performance of four popular causal inference methods us-
ing 11 RCT data sets, many more than is typically possible.
Specifically, we examine propensity-score matching (Rosen-
baum and Rubin 1983), outcome regression (Morgan and
Winship 2015), tree-based outcome modeling (Bayesian ad-
ditive regression trees (BART) (Hill 2011)), and a structure
learning method (the PC algorithm (Spirtes, Glymour, and
Scheines 2000)). Details are provided in the Supplementary
Material. We selected 11 RCTs from 6 repositories. (Mal-
Figure 3: Demonstration of OSRCT on data from 11 RCTs, split by outcome type. Top left: ATE (risk-ratio) for binary outcome,
Top right: ATE for continuous outcome, Bottom left: Outcome estimation for binary outcome, Bottom right: Outcome estimation
for continuous outcome. Outcome estimation errors were normalized by the range of the outcome. OSRCT allows us to evaluate
causal inference methods on a wide range of data sets for which unbiased effect estimates are available.
horta and Valenzuela 2012; Butler and Broockman 2011;
Gerber et al. 2014; Lahey and Costa 2011; Fitch, Carlen, and
Handy 2019; Go´mez Gras et al. 2019; Cram and Moore 2020;
Mickes 2018; Donny 2020; Pries et al. 2020; Tyler, Mahall,
and Davis 2019) For this analysis, we only selected data sets
that were publicly available for download, requiring, at most,
registering for an account with the repository. These data sets
all have binary treatment, at least one measured pre-treatment
covariate, and either a binary or a continuous outcome. For
simplicity, we chose a single biasing covariate for each data
set and applied the bias as a logistic function. We selected
biasing covariates that were correlated with outcome, so that
sub-sampling would introduce confounding. Details about
data sets are provided in the Supplementary Material.
For each data set, we applied OSRCT to create a con-
structed observational data set, learned a model using each
causal inference method, and evaluated them on their ability
to both estimate ATE and to predict the effects of treatment
on the complementary sample. For data sets with binary out-
come, risk-ratio (P (T = 1|Y = 1)/(P (T = 0|Y = 1))
was estimated as ATE. The ATE estimate was compared to
the sample ATE estimated from the original RCT data. The
errors in outcome estimation were weighted according to
P (Tsi = ti|Ci), and the mean absolute error was estimated.
We ran this procedure 30 times for each data set. For ease of
comparison, results are divided between binary and continu-
ous outcome. ATE and outcome estimation errors are shown
in Figure 3.
Performance varies significantly by data set. While some
trends appear (such as structure learning performing worse
with binary outcome), ultimately, further analysis is neces-
sary to understand what features of these data sets lead to
performance differences. It is clear, though, that data gen-
erated from OSRCT can lead to some interesting variations
in performance, and a comprehensive evaluation of causal
inference methods using RCT data is intended as future work.
Propensity score matching may have an advantage in this
evaluation, since these methods explicitly model the func-
Figure 4: APO vs RCT sampling on Postgres data. Left: Mean absolute error of ATE estimates, Right: Mean error of estimated
outcomes The similarity between the RCT and APO data sets suggests that OSRCT and OSAPO produce equivalent constructed
observational data.
tional form of treatment given covariates, which is the depen-
dence that was induced. This demonstration uses a simple
biasing function on a single covariate, likely making this an
easier problem for propensity score methods to solve. The
functional form of outcome given covariates and treatment
arises naturally and is likely to be a much more complicated
mechanism. Thus, when evaluating different classes of infer-
ence methods using OSRCT, the form of the biasing should
be varied. Structure learning methods are at a disadvantage
here. Structure learning methods first focus on learning the
causal structure of the system, and then use parameters fit
to that structure to estimate effects. Effect estimates are thus
very sensitive to the learned structure. Across the 30 runs
performed for each data set, the learned structure varies, pro-
ducing higher variance in effect estimates.
Experimental Evaluation
To assess OSRCT’s effectiveness at approximating APO data,
we performed an experiment using an APO data set provided
by Gentzel, Garant, and Jensen (2019), replicating their ex-
perimental setup. In this data, units are Postgres queries,
interventions are Postgres settings (such as type of indexing),
covariates are features of queries (such as the number of joins
or the number of rows returned), and outcomes are measured
results of running the query (such as runtime). If the Postgres
database is queried in a recoverable manner, the same query
can be run repeatedly while varying the treatment, creating
APO data. For this analysis, consistent with Gentzel, Garant,
and Jensen (2019), we chose runtime as the outcome, index-
ing level as the treatment, and the number of rows returned
by the query as the biasing covariate.
To compare RCT and APO data, We converted the APO
Postgres data into RCT-style data by randomly sampling a
single treatment for every unit. We then created constructed
observational data from both the original APO data and the
RCT-style data, creating DOSAPO and DOSRCT . For DOSRCT ,
as described in Theorem 3, outcome estimation was evalu-
ated by weighting the errors in the complementary sample.
However, in DOSAPO, no complementary sample is created,
since the selected treatment is guaranteed to be observed for
every unit. Instead, we can divide DOSAPO into training and
test sets. If the RCT-style data is created by sub-sampling
treatments equally, by Theorem 2, splitting DOSAPO in half
leads to a data set approximately the same size as DOSRCT ,
allowing for comparison with equal training set size. We es-
timated errors over 100 trials. Results are shown in Figure
4.
Results are very similar for the APO data and the RCT-
style data constructed from it. Consistent with Theorem 1,
this suggests that evaluation with OSRCT data produces
equivalent results to OSAPO data. In addition, consistent with
Theorem 3, the similarity in outcome estimates suggests that
weighting the complementary sample produces equivalent
results to an unweighted held-out test set.
Conclusion
Research progress in machine learning has long depended on
high-quality empirical evaluation. Until recently, research in
causal inference has been hindered due to an almost complete
lack of empirical data resources. The growth in such data
resources is slow, and the breadth of such data is still limited,
especially when compared to the wealth of evaluation data
sets available for associational machine learning.
Data from RCTs provides a large and growing source
of data that can be used to evaluate causal inference meth-
ods. They have the benefit of being widely collected by re-
searchers in many fields over many years, and are increas-
ingly being made available for wider use. RCT data is avail-
able from a wide variety of domains, and unbiased estimates
of causal effect can be obtained for evaluation. OSRCT can
substantially increase the data available for evaluating causal
inference methods.
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Supplementary Material
Proof of Theorem 2
Proof. Assume binary treatment T ∈ {0, 1}. For any unit i
with covariates Ci, let P (Ti = t) = pt, P (Tsi = t|Ci) =
pTsi=t|c, and n = |DRCT |. Indices are omitted when clear
from context.
P (i ∈ DOSRCT ) = p1pTsi=1|c + p0pTsi=0|c
= p1pTsi=1|c + (1− p1)(1− pTsi=1|c)
= 2p1pTsi=1|c − p1 − pTsi=1|c + 1
E[|DOSRCT |] =
n∑
i=1
[2p1pTsi=1|c − p1 − pTsi=1|c + 1]
= n− np1 + (2p1 − 1)
n∑
i=1
pTsi=1|c
If either p1 = 0.5 or
∑n
i=1 pTsi=1|c = 0.5n,E[|DOSRCT |] =
0.5n.
Proof of Theorem 3
Proof. For DOSRCT ,
E[Yˆ − Y ]DOSRCT = E[P (Tsi = ti|Ci)(Yˆi − Yi)]
For D¯OSRCT ,
E[Yˆ − Y ]D¯OSRCT = E[(1− P (Tsi = ti|Ci))(Yˆi − Yi)]
If we weight the outcome estimates for D¯OSRCT by
P (Tsi=ti|Ci)
1−P (Tsi=ti|Ci) ,
E[Yˆ − Y ]D¯OSRCT = E[
P (Tsi = t|Ci)
1− P (Tsi = ti|Ci) ·
(1− P (Tsi = ti|Ci))(Yˆi − Yi)]
= E[P (Tsi = ti|Ci)(Yˆi − Yi)]
= E[Yˆ − Y ]DOSRCT
Copyright © 2021, Association for the Advancement of Artificial
Intelligence (www.aaai.org). All rights reserved.
Details about Causal Inference Methods
Evaluated
Propensity-score matching (PSM) learns a model of treat-
ment probability that is used to produce samples with equal
probabilities of treatment. Then weighted outcome estimates
of the treatment and control populations are compared to esti-
mate ATE. PSM was implemented using the MatchIt package
in R.
For outcome regression, we can regress outcome on treat-
ment and covariates. The resulting coefficient on treatment
can be interpreted as the causal effect of treatment on out-
come. The model also produces outcome predictions for each
unit. This was implemented as linear regression for continu-
ous outcome and logistic regression for binary outcome.
BART uses a tree-based model to estimate the response
curve, allowing for estimation of both ATE and outcome. We
used the bartMachine package in R.
The PC algorithm learns the structure of causal depen-
dencies among a set of variables and produces a structural
causal model. Parameters can be fit to the resulting model to
answer conditional probability queries, allowing estimation
of ATE and prediction of outcome under intervention. When
a Markov equivalence class of structures was produced, we
sampled a random member of that class. We discretized all
covariates, and used the pc.stable implementation of the PC
algorithm in the bnlearn package in R.
Details about RCT Repositories
We selected data sets from six repositories: (1) Dryad (?); (2)
the Yale Institution for Social and Policy Studies Repository
(?); (3) the NIH National Institute on Drug Abuse Data Share
Website (?); (4) the University of Michigan’s ICPSR reposi-
tory (?); (5) the UK Data Service (?); and (6) the Knowledge
Network for Biocomplexity (?). These repositories were se-
lected because they contained RCT data, were reasonably
well-documented, and had a simple access process. None
of these repositories house RCT data exclusively, so some
search and filtering was necessary to identify relevant data
sets.
Many other repositories exist that contain RCT data but
have higher access restrictions. Access to these repositories
generally involves requesting permission for any desired data
set. For some, this request only involves submitting a brief
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Repository ID Coding Sample Treatment Outcome Biasing
Size Covariate
Dryad 6d4p06g D-2 6453 Temperature Plant health Species
Dryad B8KG77 D-2 15289 Video type Bicycle rating Bike access
ICPSR 23980 C-1 10098 Age Resume response Volunteer service
ISPS d037 I-1 4859 Race Legislator response Party
ISPS d084 I-2 48509 E-mail source Voter turnout Prior election turnout
ISPS d113 I-3 10200 Mailing Voter turnout Gender
KNB 1596312 K-1 760 Soil heating C02 levels Depth
KNB f1qf8r51t K-2 8063 Plant protection Plant survival Location
NIDA P1S1 N-1 776 Nicotine levels Cigarettes per day Weight
UK Data Service 853369 U-1 4210 Biasing instruction Line-up identification Recruitment method
UK Data Service 854092 U-2 691 Fact check validity Reaction Political activity
Table 1: Data sets used in demonstration. ‘Coding’ denotes the shortened data set name used in Figure 3 in the paper.
description of the intended use and proving sufficient cre-
dentials. For others, this request may require a detailed data
analysis plan and description of the benefits of the research.
Examples include the National Institute of Diabetes and Di-
gestive and Kidney Diseases (?), Vivli (?), The National
Institute of Mental Health Data Archive (?), Project Data
Sphere (?), and the Data Observation Network for Earth (?).
Details about RCT Data Sets Used in
Demonstration
The data sets used in the demonstration came from six repos-
itories, all of which allowed for direct download of the data
after registering with the repository. Each of these data sets
met five criteria:
Random assignment: Treatment must be fully randomized
for OSRCT to work as intended. We ensured that the se-
lected data sets were created by randomly assigning treat-
ment to each unit.
Independent units: Many causal inference methods assume
independent data instances, so we ensured that the units
in the data sets could reasonably be assumed independent
(e.g., no spatial correlation).
Measured pre-treatment covariate: At least one mea-
sured pre-treatment covariate is necessary to induce con-
founding bias. The data sets we selected all had multiple
pre-treatment covariates, allowing us to select one that was
correlated with outcome to induce confounding bias.
Reasonably large sample size: Many RCT data sets are
very small (N < 100). We selected only reasonably large
data sets (N > 500).
Ease of use: Some data sets were poorly documented or
stored the data over many files. We selected data sets that
would require minimal pre-processing.
In cases where treatment was not binary, a reasonable bi-
nary version of treatment was constructed, either by grouping
merging treatment categories or by selecting a subset of the
data with only two values of treatment. Details about these
data sets are given in Table 1.
Broader Impact
This work has the potential to make a positive impact on the
ability to evaluate methods for causal inference. Causal in-
ference methods are being used in practice regularly in many
domains and have broad societal implications. For example,
causal reasoning is necessary to understand the effects of
policy changes and to estimate the effectiveness of medical
interventions. This work deals with improving the breadth
of evaluation options for causal inference methods. Better
evaluation of such methods can improve our understanding
of how, and under what circumstances, these methods can
perform. This understanding can guide decisions about what
methods to use in practice, and can also guide researchers to
develop better methods that improve on their shortcomings.
This work relies on using existing RCT data to perform
evaluation. Many RCTs are designed to answer a specific
causal question, and once the data has been analyzed for
that purpose, are not used again. This work encourages the
re-use of RCT data, increasing the value of such data beyond
the original intended study. However, many RCTs are per-
formed on human subjects, with strict privacy and security
requirements and concerns. Any RCT data obtained from
a repository should be stored and used only in the manner
approved by that repository, and no attempts should be made
to de-anonymize the data. While many RCT data sets can be
obtained and used for evaluation of causal inference methods,
there are also many data sets that are only available under
very strict usage requirements and that require the submission
of a detailed data analysis plan beforehand. If researchers
collect RCT data for the purpose of evaluating with OSRCT
without properly respecting the limitations and requirements
of both the repositories that host that data and the researchers
that originally collected that data, that would constitute a
breach of privacy for the subjects of the trial. Thus, care
should be taken when storing and working with this data.
